Inovio Pharmaceuticals
INO
INO
198 hedge funds and large institutions have $330M invested in Inovio Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 55 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
198
Holders Change
-10
Holders Change %
-4.81%
% of All Funds
3.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
53
Reduced
55
Closed
31
Calls
$3.87M
Puts
$5.47M
Net Calls
-$1.61M
Net Calls Change
+$1.07M
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$83.5M |
| 2 |
2
Two Sigma Investments
New York
|
$8.4M |
| 3 |
3
Morgan Stanley
New York
|
$5.94M |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$5.89M |
| 5 |
5
Bank of America
Charlotte,
North Carolina
|
$5.21M |
